UB Paderborn / Katalog / Suche / in CDI

ChIP-seq and in vivo transcriptome analyses of the Aspergillus fumigatus SREBP SrbA reveals a new regulator of the fungal hypoxia response and virulence

PLoS pathogens, 2014-11, Vol.10 (11), p.e1004487-e1004487

2014

Volltextzugriff (PDF)

Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States

The Journal of infectious diseases, 2017-11, Vol.216 (9), p.1053-1062

2017

Volltextzugriff (PDF)

SREBP-Dependent Triazole Susceptibility in Aspergillus fumigatus Is Mediated through Direct Transcriptional Regulation of erg11A (cyp51A)

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.248-257

2012

Volltextzugriff (PDF)

Analytical evaluation of the cobas® 6800 system for the detection and quantification of BK Virus (BKV) and Epstein Barr Virus (EBV) at a US solid organ and hematopoietic stem cell transplant center

Diagnostic microbiology and infectious disease, 2023-03, Vol.105 (3), p.115884-115884, Article 115884

2023

Volltextzugriff (PDF)

In Vitro Antimicrobial Activity of Doripenem, a New Carbapenem

Antimicrobial Agents and Chemotherapy, 2004-04, Vol.48 (4), p.1384-1396

2004

Volltextzugriff (PDF)

Multicenter Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Study for Identification of Clinically Relevant Nocardia spp

Journal of clinical microbiology, 2016-05, Vol.54 (5), p.1251-1258

2016

Volltextzugriff (PDF)

Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation

Microbes and infection, 2013-04, Vol.15 (4), p.259-269

2013

Volltextzugriff (PDF)

Two C4-sterol methyl oxidases (Erg25) catalyse ergosterol intermediate demethylation and impact environmental stress adaptation in Aspergillus fumigatus

Microbiology (Society for General Microbiology), 2014-11, Vol.160 (Pt 11), p.2492

2014

Volltextzugriff (PDF)

Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001

Antimicrobial Agents and Chemotherapy, 2003-05, Vol.47 (5), p.1689-1693

2003

Volltextzugriff (PDF)

In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000–2001

Clinical microbiology and infection, 2003-07, Vol.9 (7), p.590-599

2003

Volltextzugriff (PDF)

Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus

Molecular microbiology, 2014-06, Vol.92 (6), p.1279-1298

2014

Volltextzugriff (PDF)

In Vitro Activities of Novel Nonfluorinated Quinolones PGE 9262932 and PGE 9509924 against Clinical Isolates of Staphylococcus aureus and Streptococcus pneumoniae with Defined Mutations in DNA Gyrase and Topoisomerase IV

Antimicrobial Agents and Chemotherapy, 2002-06, Vol.46 (6), p.1651-1657

2002

Volltextzugriff (PDF)

Antimicrobial Surveillance of Haemophilus influenzae in the United States during 2000-2001 Leads to Detection of Clonal Dissemination of a β-Lactamase-Negative and Ampicillin-Resistant Strain

Journal of Clinical Microbiology, 2002-03, Vol.40 (3), p.1063-1066

2002

Volltextzugriff (PDF)

Carbapenemase production among less-common Enterobacterales genera: 10 US sites, 2018

JAC-antimicrobial resistance, 2021-09, Vol.3 (3), p.dlab137-dlab137

2021

Volltextzugriff (PDF)

Longitudinal Assessment of Antipneumococcal Susceptibility in the United States

Antimicrobial Agents and Chemotherapy, 2002-08, Vol.46 (8), p.2651-2655

2002

Volltextzugriff (PDF)

The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002

Diagnostic microbiology and infectious disease, 2003-12, Vol.47 (4), p.579-586

2003

Volltextzugriff (PDF)

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999–2000

International journal of antimicrobial agents, 2002-08, Vol.20 (2), p.100-107

2002

Volltextzugriff (PDF)

Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92

Microbial pathogenesis, 2007-08, Vol.43 (2), p.67-77

2007

Volltextzugriff (PDF)

Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001

Clinical microbiology and infection, 2003-05, Vol.9 (5), p.431-436

2003

Volltextzugriff (PDF)

Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000–2001: a comparison with other β-lactam agents

Journal of antimicrobial chemotherapy, 2003-01, Vol.51 (1), p.196-199

2003

Volltextzugriff (PDF)

Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999

Diagnostic microbiology and infectious disease, 2002-02, Vol.42 (2), p.129-135

2002

Volltextzugriff (PDF)

Reinterpretation of susceptibility data using current NCCLS breakpoint criteria

Antimicrobial agents and chemotherapy, 2003-02, Vol.47 (2), p.830-830

2003

Volltextzugriff (PDF)

The Activity of Levofloxacin and Comparator Agents against Clinical Isolates of Streptococcus pneumoniae Collected Worldwide during 1999 and 2000

Chemotherapy (Basel), 2002-12, Vol.48 (5), p.232-237

2002

Volltextzugriff (PDF)

Apparent plateau in β-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative

International journal of antimicrobial agents, 2002-02, Vol.19 (2), p.119-123

2002

Volltextzugriff (PDF)

Characterization of Klebsiella isolates from natural receiving waters and comparison with human isolates

Applied microbiology, 1974-10, Vol.28 (4), p.672

1974

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

ChIP-seq and in vivo transcriptome analyses of the Aspergillus fumigatus SREBP SrbA reveals a new regulator of the fungal hypoxia response and virulence

Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States

SREBP-Dependent Triazole Susceptibility in Aspergillus fumigatus Is Mediated through Direct Transcriptional Regulation of erg11A (cyp51A)

Analytical evaluation of the cobas® 6800 system for the detection and quantification of BK Virus (BKV) and Epstein Barr Virus (EBV) at a US solid organ and hematopoietic stem cell transplant center

In Vitro Antimicrobial Activity of Doripenem, a New Carbapenem

Multicenter Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Study for Identification of Clinically Relevant Nocardia spp

Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation

Two C4-sterol methyl oxidases (Erg25) catalyse ergosterol intermediate demethylation and impact environmental stress adaptation in Aspergillus fumigatus

Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001

In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000–2001

Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus

In Vitro Activities of Novel Nonfluorinated Quinolones PGE 9262932 and PGE 9509924 against Clinical Isolates of Staphylococcus aureus and Streptococcus pneumoniae with Defined Mutations in DNA Gyrase and Topoisomerase IV

Antimicrobial Surveillance of Haemophilus influenzae in the United States during 2000-2001 Leads to Detection of Clonal Dissemination of a β-Lactamase-Negative and Ampicillin-Resistant Strain

Carbapenemase production among less-common Enterobacterales genera: 10 US sites, 2018

Longitudinal Assessment of Antipneumococcal Susceptibility in the United States

The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999–2000

Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92

Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001

Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000–2001: a comparison with other β-lactam agents

Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999

Reinterpretation of susceptibility data using current NCCLS breakpoint criteria

The Activity of Levofloxacin and Comparator Agents against Clinical Isolates of Streptococcus pneumoniae Collected Worldwide during 1999 and 2000

Apparent plateau in β-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative

Characterization of Klebsiella isolates from natural receiving waters and comparison with human isolates

Aktive Filter

Suchergebnisse filtern